Facilitating Treatment Initiation in Early-Stage Alzheimer Disease

Abstract

Once a diagnosis of Alzheimer disease is established, a wide variety of therapy options are available to treat different stages of the disease. Patients have the opportunity to delay onset of the disease or delay its progression if diagnosed early enough through new FDA-approved disease-modifying treatments. For mild to moderate stages, new symptomatic treatments can slow the progression of the disease and improve symptoms.  A multi-component approach is recommended in order to tailor treatments to each patient’s needs.